Global Tetraspecific Antibodies Clinical Trials & Market Report 2024: Pioneering the Future of Cancer Treatment, Shift Towards Tetraspecific Antibodies Amidst Drug Resistance Challenges [Y...
Molecular Partners AG - American Depositary Shares (MOLN)
Company Research
Source: Yahoo! Finance
Global Tetraspecific Antibodies Clinical Trials & Market Opportunity Insight 2024 Report Highlights: First Tetraspecific Antibody Expected Approval by 2029 China Dominating Global Tetraspecific Development Landscape Tetraspecific Antibodies Clinical Trials Insight by Company, Country, Indication & Phase Tetraspecific Antibody Clinical Development Trend Analysis by Region: China, Europe & USA Tetraspecific Development Proprietary Technologies by Company Combination Stratagems for Tetraspecific Antibodies The triumph in the domain of immunotherapies, like antibody therapies, has predisposed the future of multispecific antibodies; one such is tetraspecific approach. Given the ability of tetraspecific antibodies of binding more than the target, this class of multispecific antibodies had practical advantages in applications on the subject of bringing four targets in closer proximity. Therefore, by leveraging the potential of tetraspecific antibodies field offers a novel appr
Show less
Read more
Impact Snapshot
Event Time:
MOLN
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
MOLN alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
MOLN alerts
High impacting Molecular Partners AG - American Depositary Shares news events
Weekly update
A roundup of the hottest topics
MOLN
News
- Molecular Partners to Present at The TD Cowen Radiopharmaceutical Innovation SummitGlobeNewswire
- Molecular Partners Presents Positive Preclinical Data for First Switch-DARPin Candidate MP0621 at EHA 2024 [Yahoo! Finance]Yahoo! Finance
- Molecular Partners Presents Positive Preclinical Data for First Switch-DARPin Candidate MP0621 at EHA 2024GlobeNewswire
- Molecular Partners and Orano Med Share Positive Preclinical Data of their DLL3-Targeting Radio-DARPin Therapy (RDT) Candidate MP0712 at SNMMI 2024 [Yahoo! Finance]Yahoo! Finance
- Molecular Partners and Orano Med Share Positive Preclinical Data of their DLL3-Targeting Radio-DARPin Therapy (RDT) Candidate MP0712 at SNMMI 2024GlobeNewswire
MOLN
Sec Filings
- 6/14/24 - Form 6-K
- 6/11/24 - Form 6-K
- 6/3/24 - Form 6-K
- MOLN's page on the SEC website